Current status and vision of local pharmaceutical industries in Saudi Arabia: The focus on nanomedicines
Background: Pharmaceutical nanomedicine products are expected to impact the global pharmaceutical market and healthcare system significantly. Since 2000, the Food and Drug Administration (FDA) and European Medicines Agency (EMA) have approved over 80 nanomedicine products for marketing; an additiona...
Saved in:
Main Authors: | Abdulrahman A. Halwani (Author), Bander Balkhi (Author), Abdullah A. Alamoudi (Author), Nada H. Almozain (Author), Areej M. Alajmi (Author), Abdulwahab Noorwali (Author), Moutaz Y. Badr (Author), Ahmad O. Noor (Author), Alaa Bagalagel (Author), Essam A. Tawfik (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antimicrobial Resistance Awareness, Antibiotics Prescription Errors and Dispensing Patterns by Community Pharmacists in Saudi Arabia
by: Areej M. Alajmi, et al.
Published: (2023) -
Localizing pharmaceuticals manufacturing and its impact on drug security in Saudi Arabia
by: Essam A. Tawfik, et al.
Published: (2022) -
Development of Pharmaceutical Nanomedicines: From the Bench to the Market
by: Abdulrahman A. Halwani
Published: (2022) -
Cross-national comparative study of orphan drug policies in Saudi Arabia, the United States, and the European Union
by: Bander Balkhi, et al.
Published: (2023) -
Pharmacy students attitude and perception toward working in community pharmacy in Saudi Arabia
by: Bander Balkhi, et al.
Published: (2020)